No. | Age/Sex | Dose (Gy) | Primary Adjacent to Hyoid | Post-XRT ORN DX (mo) | Preceding Soft-Tissue Ulceration | Adjacent Enhancement | Post-ORN Follow-Up (mo) |
---|---|---|---|---|---|---|---|
1 | 67/M | OSH-N/A | – | 34 | No | Yes | 12 |
2 | 46/M | 71 | Yes | 5 | No | No | 6 |
3 | 66/Ma | 60, 50.2 | No | 2 | No | Yes | 23 |
4 | 64/M | 70.0 | Yes | 5 | Yes | No | 30 |
5 | 45/M | 66.8 | Yes | 5.5 | Yes | No | 1 |
6 | 64/M | 70.6 | Yes | 13 | No | No | 16 |
7 | 54/M | 70.1 | Yes | 8 | No | No | 7 |
8 | 49/M | 71.6 | Yes | 26 | No | No | 16 |
9 | 70/M | 60, 20 | – | 6 | No | No | 14 |
10 | 67/M | OSH-N/A | – | 1 | No | No | 21 |
11 | 47/M | OSH-N/A | – | 32 | Yes | Yes | 7 |
12 | 67/M | 41, 63 | Yes | 10 | Yes | Yes | 2 |
13 | 61/M | 50, 60 | – | 17 | Yes | Yes | 4 |
Patient was originally radiated for metastasis to the neck (60 Gy), primary unknown, and subsequently re-irradiated (50.2 Gy) for a pharyngeal wall squamous cell carcinoma.